Roland Baumgartner

Publications
Public outreach and news

Articles

Article: CARDIOVASCULAR RESEARCH (CVR). 2020;116(12):1948-1957
3-Hydroxyanthralinic acid metabolism controls the hepatic SREBP/lipoprotein axis, inhibits inflammasome activation in macrophages, and decreases atherosclerosis in Ldlr^-/- mice
Berg M; Polyzos KA; Agardh H; Baumgartner R; Forteza MJ; Kareinen I; Gistera A; Bottcher G; Hurt-Camejo E; Hansson GK; Ketelhuth DFJ
Article: STEM CELL RESEARCH AND THERAPY. 2019;10(1):371
Immunomodulatory effects of interferon-γ on human fetal cardiac mesenchymal stromal cells
Grinnemo K-H; Lofling M; Nathanson L; Baumgartner R; Ketelhuth DFJ; Beljanski V; Davies LC; Osterholm C
Article: CYTOKINE. 2019;122:154148
The interplay between cytokines and the Kynurenine pathway in inflammation and atherosclerosis
Baumgartner R; Forteza MJ; Ketelhuth DFJ
Article: SCIENTIFIC REPORTS. 2019;9(1):12150
Exhaustion of CD4+T-cells mediated by the Kynurenine Pathway in Melanoma
Pour SR; Morikawa H; Kiani N; Yang M; Azimi A; Shafi G; Shang M; Baumgartner R; Ketelhuth DFJ; Kamleh MA; Wheelock CE; Lundqvist A; Hansson J; Tegner J
Article: EUROPEAN HEART JOURNAL. 2019;40(30):2495-2503
Prevention of radiotherapy-induced arterial inflammation by interleukin-1 blockade
Christersdottir T; Pirault J; Gistera A; Bergman O; Gallina AL; Baumgartner R; Lundberg AM; Eriksson P; Yan Z-Q; Paulsson-Berne G; Hansson GK; Olofsson PS; Halle M
Article: CIRCULATION. 2019;139(21):2466-2482
Germinal Center-Derived Antibodies Promote Atherosclerosis Plaque Size and Stability
Centa M; Jin H; Hofste L; Hellberg S; Busch A; Baumgartner R; Verzaal NJ; Enoksson SL; Matic LP; Boddul SV; Atzler D; Li DY; Sun C; Hansson GK; Ketelhuth DFJ; Hedin U; Wermeling F; Lutgens E; Binder CJ; Maegdesfessel L; Malin SG
Article: INTERNATIONAL JOURNAL OF NANOMEDICINE. 2019;14:3723-3741
Human serum albumin-based probes for molecular targeting of macrophage scavenger receptors
Ahmed M; Baumgartner R; Aldi S; Dusart P; Hedin U; Gustafsson B; Caidahl K
Article: CIRCULATION. 2018;138(16):1693-1705
ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages
Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gistera A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Back M
Article: FRONTIERS IN IMMUNOLOGY. 2018;9:950
Activation of the Regulatory T-Cell/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice
Forteza MJ; Polyzos KA; Baumgartner R; Suur BE; Mussbacher M; Johansson DK; Hermansson A; Hansson GK; Ketelhuth DFJ
Article: CARDIOVASCULAR RESEARCH (CVR). 2015;106(2):295-302
Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice
Polyzos KA; Ovchinnikova O; Berg M; Baumgartner R; Agardh H; Pirault J; Gistera A; Assinger A; Laguna-Fernandez A; Baeck M; Hansson GK; Ketelhuth DFJ

All other publications

Editorial comment: ATHEROSCLEROSIS. 2014;237(2):809-810
Biglycan: Unpuzzling the causal links between tobacco-smoking and atherosclerosis?
Baumgartner R

Articles

All other publications

News from KI

Events from KI